Sphere: Related Content
Sunday, January 25, 2009
Update to Wyeth and Pfizer Deal
Just released from the WSJ, Pfizer is doing a 2/3 cash deal 1/3 stock deal for roughly $50.19 a share. As stated in the previous blog entry this should heat up the sector and bring speculation to names similar to Wyeth.
Sphere: Related Content
Sphere: Related Content
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment